The Relationship Between Functional Independence and Family Well-being in Children With Rare Genetic Disorders
Examination of Families' Psychological Status and Quality of Life According to the Functional Independence Status of Children With Rare Genetic Diseases in Early Childhood
1 other identifier
observational
45
1 country
1
Brief Summary
This study aims to examine the psychological status and quality of life of families with children who have rare genetic disorders. The focus of the study is to understand how the child's level of functional independence relates to the well-being of the family. Functional independence will be assessed using standardized tools, and parental psychological status and quality of life will be evaluated with validated questionnaires. The information gathered from this study may help improve the understanding of how rare genetic disorders affect family dynamics and daily functioning. The results may guide health care professionals in planning family-centered physiotherapy, psychological support, and care programs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 25, 2025
CompletedFirst Submitted
Initial submission to the registry
December 11, 2025
CompletedFirst Posted
Study publicly available on registry
January 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 25, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2026
CompletedJanuary 16, 2026
January 1, 2026
4 months
December 11, 2025
January 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional Independence Level of the Child (WeeFIM)
The functional independence level of children with rare genetic disorders will be assessed using the Pediatric Functional Independence Measure (WeeFIM). This scale evaluates functional abilities in self-care, mobility, and cognition. Higher scores indicate greater functional independence.
At baseline (study enrollment)
Secondary Outcomes (5)
Beck Depression Inventory (BDI)
At baseline (study enrollment)
Family Functionality in Rehabilitation
At baseline (study enrollment)
Family Impact (Family Impact Scale)
At baseline (study enrollment)
Sleep Quality (Pittsburgh Sleep Quality Index - PSQI)
At baseline (study enrollment)
Quality of Life (Nottingham Health Profile - NHP)
At baseline (study enrollment)
Study Arms (2)
Lower Functional Independence
Children with rare genetic disorders whose functional independence level is lower based on the Pediatric Functional Independence Measure (WeeFIM). Caregivers of these children are included in the study.
Higher Functional Independence
Children with rare genetic disorders whose functional independence level is higher based on the Pediatric Functional Independence Measure (WeeFIM). Caregivers of these children are included in the study.
Eligibility Criteria
The study population consists of caregivers of children aged 0-4 years who have been diagnosed with rare genetic disorders and receive physiotherapy services at a rehabilitation center in Istanbul, Turkey. Participants are primary caregivers responsible for the child's daily care and able to complete Turkish-language questionnaires. The population reflects a clinical sample receiving ongoing rehabilitation, rather than a community-based or general population sample
You may qualify if:
- Caregivers of children aged 0-4 years diagnosed with a rare genetic disorder.
- The child must have been receiving physiotherapy for at least 6 months.
- Caregivers who voluntarily agree to participate and provide informed consent.
- Caregivers who are able to read and understand Turkish to complete the questionnaires.
You may not qualify if:
- Caregivers who have cognitive or language limitations that prevent them from completing the questionnaires.
- Caregivers who decline participation or submit incomplete questionnaire forms.
- Children or caregivers with an additional medical or neurological condition that prevents participation in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bahcesehir University
Istanbul, 34053, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tuğçe Tahmaz, PhD
Bahçeşehir University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Graduate Student Researcher
Study Record Dates
First Submitted
December 11, 2025
First Posted
January 16, 2026
Study Start
October 25, 2025
Primary Completion
February 25, 2026
Study Completion
March 15, 2026
Last Updated
January 16, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share